Prostate Cancer Clinical Trial
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy
Summary
This pilot phase II trial studies how well vitamin B6 works in reducing hot flashes in participants with prostate cancer undergoing antiandrogen therapy. A nutritional supplement such as vitamin B6 may help improve hot flashes caused by antiandrogen therapy in participants with prostate cancer.
Full Description
PRIMARY OBJECTIVES:
I. To evaluate the effect of Vitamin B6 in improves the frequency or severity of hot flashes in prostate cancer patients receiving antiandrogen therapy (androgen deprivation therapy [ADT]).
Eligibility Criteria
Inclusion Criteria:
Subjects are currently receiving ADT for prostate cancer and will continue on ADT for at least 13 weeks after enrollment. Patient may have been started on ADT at any past time point because patients experience hot flashes throughout ADT treatment
Subjects are experiencing bothersome hot flashes per the study questionnaires
Subjects are capable of giving informed consent.
Willing to comply with all study procedures and be available for the duration of the study
Able to obtain and take an acceptable form of vitamin B6
Exclusion Criteria:
Subjects without a diagnosis of prostate cancer
Subjects already receiving other treatment for hot flashes
Subjects taking selective serotonin reuptake inhibitors (SSRIs)
Subjects are currently taking vitamin supplementation which includes vitamin B6 at doses > 10 mg
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19107, United States More Info
Principal Investigator
How clear is this clinincal trial information?